logo
Share SHARE
FONT-SIZE Plus   Neg

Coronado Biosciences Prices Public Offering Of 5 Mln Shares At $5.00/shr

Coronado Biosciences Inc. (CNDO) announced the pricing of its underwritten public offering of 5 million shares of its common stock at a price to the public of $5.00 per share for gross proceeds to Coronado of $25.0 million.

Coronado said it expects to receive approximately $23.0 million in net proceeds from the offering, after deducting underwriting discount and estimated offering expenses.

The company also has granted the underwriters a 30-day option to purchase up to an aggregate of 750,000 additional shares of common stock to cover over-allotments, if any. The offering is expected to close on June 27, 2012, subject to customary closing conditions.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The recent week marked the lull before the storm, with very few market moving economic numbers released during the week. However, the economic news flow picks up pace in the upcoming week, offering glimpses into every vehicle of economic growth, ranging from consumers to private sector activity to housing.... Life expectancy at birth in the U.S. is already lower than most other developed nations and is now projected to fall further behind by 2030, according to a new study. It also suggests that by 2030, national female life expectancy in South Korea could break the 90 year barrier. Department store chain J.C. Penney Co. Inc. on Friday reported a turnaround to profit in the fourth quarter as a slight decline in sales was more than offset by lower expenses. Adjusted earnings per share for the quarter beat analysts' expectations, while revenues slightly missed their estimates. Earlier today, J.C. Penny announced a plan to optimize its national retail operations.
comments powered by Disqus
Follow RTT